Pott's Spine with Tubercular Meningitis and Primary Optic Atrophy
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Intracranial Actinomycosis of Odontogenic Origin Masquerading As Auto-Immune Orbital Myositis: a Fatal Case and Review of the Literature G
Hötte et al. BMC Infectious Diseases (2019) 19:763 https://doi.org/10.1186/s12879-019-4408-2 CASE REPORT Open Access Intracranial actinomycosis of odontogenic origin masquerading as auto-immune orbital myositis: a fatal case and review of the literature G. J. Hötte1,2*, M. J. Koudstaal3, R. M. Verdijk4, M. J. Titulaer5, J. F. H. M. Claes6, E. M. Strabbing3, A. van der Lugt7 and D. Paridaens1,2 Abstract Background: Actinomycetes can rarely cause intracranial infection and may cause a variety of complications. We describe a fatal case of intracranial and intra-orbital actinomycosis of odontogenic origin with a unique presentation and route of dissemination. Also, we provide a review of the current literature. Case presentation: A 58-year-old man presented with diplopia and progressive pain behind his left eye. Six weeks earlier he had undergone a dental extraction, followed by clindamycin treatment for a presumed maxillary infection. The diplopia responded to steroids but recurred after cessation. The diplopia was thought to result from myositis of the left medial rectus muscle, possibly related to a defect in the lamina papyracea. During exploration there was no abnormal tissue for biopsy. The medial wall was reconstructed and the myositis responded again to steroids. Within weeks a myositis on the right side occurred, with CT evidence of muscle swelling. Several months later he presented with right hemiparesis and dysarthria. Despite treatment the patient deteriorated, developed extensive intracranial hemorrhage, and died. Autopsy showed bacterial aggregates suggestive of actinomycotic meningoencephalitis with septic thromboembolism. Retrospectively, imaging studies showed abnormalities in the left infratemporal fossa and skull base and bilateral cavernous sinus. -
A Case of Miliary Tuberculosis Presenting with Whitlow of the Thumb
A Case of Miliary Tuberculosis Presenting with Whitlow of the Thumb Romaric Larcher, Albert Sotto, Jean-Marc Mauboussin, Jean-Philippe Lavigne, François-Xavier Blanc, Didier Laureillard To cite this version: Romaric Larcher, Albert Sotto, Jean-Marc Mauboussin, Jean-Philippe Lavigne, François-Xavier Blanc, et al.. A Case of Miliary Tuberculosis Presenting with Whitlow of the Thumb. Acta Dermato- Venereologica, Society for Publication of Acta Dermato-Venereologica, 2016, 96 (4), pp.560 - 561. 10.2340/00015555-2285. hal-01909474 HAL Id: hal-01909474 https://hal.archives-ouvertes.fr/hal-01909474 Submitted on 25 May 2021 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution - NonCommercial| 4.0 International License Acta Derm Venereol 2016; 96: 560–561 SHORT COMMUNICATION A Case of Miliary Tuberculosis Presenting with Whitlow of the Thumb Romaric Larcher1, Albert Sotto1*, Jean-Marc Mauboussin1, Jean-Philippe Lavigne2, François-Xavier Blanc3 and Didier Laureillard1 1Infectious Disease Department, 2Department of Microbiology, University Hospital Caremeau, Place du Professeur Robert Debré, FR-0029 Nîmes Cedex 09, and 3L’Institut du Thorax, Respiratory Medicine Department, University Hospital, Nantes, France. *E-mail: [email protected] Accepted Nov 10, 2015; Epub ahead of print Nov 11, 2015 Tuberculosis remains a major public health concern, accounting for millions of cases and deaths worldwide. -
Evaluation of the Various Clinical Presentations Of
EVALUATION OF THE VARIOUS CLINICAL PRESENTATIONS OF ADULT CNS TUBERCULOSIS JOY KMNI1, KUNDU NC2, AKHTER M3, HOSSAIN MZ4, RAHMAN AHMW5, RAHMAN MM6, SAIFULLAH M7, ROUF MA8, HAQUE MM9 Abstract: Background: Central nervous system (CNS) involvement is one of the most important extra- pulmonary manifestations of tuberculosis (TB) causing considerable mortality and morbidity. Presentations of CNS TB are extremely variable. Treatments are generally more effective if the disease can be detected early. This study is to find out the various clinical patterns and investigation findings that might help in early detection of CNS TB. Objective: This study was conducted to detect various clinical manifestations of adult CNS TB at an earlier stage of evaluation. Methods: This was a hospital based observational study (cross sectional type) conducted on 30 patients of CNS TB who were admitted in Sir Salimullah Medical College Mitford Hospital, Dhaka during a period of 6 months from October 2013 to April 2014 . Results: Among the participants 53% were male and 47% were female, with a male female ratio of 1.13: 1. Mean age of the participants was 35.17±6.14 years. Tuberculosis involving brain (i.e. cranial TB) was most common (30.4%) in 15-24 years age group whereas spinal form of TB was most common (42.8%) in 25-34 years age group. Mean age of the participants having Brain TB was 36.46±6.90 years. Mean age of the participants having spinal TB was 32.36±12.52 years. Highest number of the cranial forms of TB was tuberculoma (52.2%) in this study and was found mostly in the young adults. -
Case Report Left Lateral Cervical Mass with Draining Sinuses
Hindawi Case Reports in Medicine Volume 2019, Article ID 7838596, 6 pages https://doi.org/10.1155/2019/7838596 Case Report Left Lateral Cervical Mass with Draining Sinuses Stylianos A. Michaelides ,1,† George D. Bablekos ,2 Avgerinos-Romanos Michailidis,1 Efthalia Gkioxari,3 Stephanie Vgenopoulou,4 and Maria Chorti4 1Department of Occupational Lung Diseases and Tuberculosis, “Sismanogleio- Amalia Fleming” General Hospital, 1 Sismanogleiou Str, 15126, Attiki, Maroussi, Athens, Greece 2Departments of Biomedical Sciences, Nursing and Physiotherapy, University of West Attica, Campus 1, Attiki, Egaleo, Agiou Spiridonos, 12243 Athens, Greece 3Second Department of 2oracic Medicine, “Sismanogleio- Amalia Fleming” General Hospital, 1 Sismanogleiou Str, 15126, Attiki, Maroussi, Athens, Greece 4Department of Surgical Pathology, “Sismanogleio- Amalia Fleming” General Hospital, 1 Sismanogleiou Str, 15126, Attiki, Maroussi, Athens, Greece †Deceased Correspondence should be addressed to George D. Bablekos; [email protected] Received 3 January 2019; Accepted 27 May 2019; Published 25 July 2019 Academic Editor: Gerd J. Ridder Copyright © 2019 Stylianos A. Michaelides et al. *is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. *e aim of the present study is to describe an uncommon case of tuberculous lymphadenitis (TL) in a symptomless 89-year-old male smoker patient, who presented at the emergency department of our hospital with left lateral cervical swelling with draining sinuses. No other clinical symptoms or physical findings were observed at admission. An elevated erythrocyte sedimentation rate (ESR) and a small calcified nodule in chest CT were the only abnormal findings. -
A Diagnostic Rule for Tuberculous Meningitis Arch Dis Child: First Published As 10.1136/Adc.81.3.221 on 1 September 1999
Arch Dis Child 1999;81:221–224 221 A diagnostic rule for tuberculous meningitis Arch Dis Child: first published as 10.1136/adc.81.3.221 on 1 September 1999. Downloaded from Rashmi Kumar, S N Singh, Neera Kohli Abstract onstration of mycobacteria in cerebrospinal Diagnostic confusion often exists between fluid (CSF), by direct staining or culture. tuberculous meningitis and other menin- However, these tests are time consuming and goencephalitides. Newer diagnostic tests seldom positive.2 Recognising this problem of are unlikely to be available in many coun- diagnosis, many newer tests have been devel- tries for some time. This study examines oped to diagnose tuberculous meningitis and which clinical features and simple labora- diVerentiate it from pyogenic meningitis—for tory tests can diVerentiate tuberculous example, enzyme linked immunosorbent assay, meningitis from other infections. Two bromide partition test, tuberculostearic acid in hundred and thirty two children (110 CSF, adenosine deaminase in CSF, polymerase tuberculous meningitis, 94 non- chain reaction, etc.34 However, the sensitivity tuberculous meningitis, 28 indeterminate) of these tests is still under study and they are with suspected meningitis and cerebrospi- unlikely to be available where they are really nal fluid (CSF) pleocytosis were enrolled. needed for at least the next decade. In practice, Tuberculous meningitis was defined as in India, treatment is started solely on the basis positive CSF mycobacterial culture or of clinical features and results of simple labora- acid fast bacilli stain, or basal enhance- tory tests of CSF and blood. Therefore, we ment or tuberculoma on computed tomo- attempted to establish a clinical rule for the graphy (CT) scan with clinical response to diagnosis of tuberculous meningitis, whereby a antituberculous treatment. -
Chapter 2, Transmission and Pathogenesis of Tuberculosis (TB)
Chapter 2 Transmission and Pathogenesis of Tuberculosis Table of Contents Chapter Objectives . 19 Introduction . 21 Transmission of TB . 21 Pathogenesis of TB . 26 Drug-Resistant TB (MDR and XDR) . 35 TB Classification System . 39 Chapter Summary . 41 References . 43 Chapter Objectives After working through this chapter, you should be able to • Identify ways in which tuberculosis (TB) is spread; • Describe the pathogenesis of TB; • Identify conditions that increase the risk of TB infection progressing to TB disease; • Define drug resistance; and • Describe the TB classification system. Chapter 2: Transmission and Pathogenesis of Tuberculosis 19 Introduction TB is an airborne disease caused by the bacterium Mycobacterium tuberculosis (M. tuberculosis) (Figure 2.1). M. tuberculosis and seven very closely related mycobacterial species (M. bovis, M. africanum, M. microti, M. caprae, M. pinnipedii, M. canetti and M. mungi) together comprise what is known as the M. tuberculosis complex. Most, but not all, of these species have been found to cause disease in humans. In the United States, the majority of TB cases are caused by M. tuberculosis. M. tuberculosis organisms are also called tubercle bacilli. Figure 2.1 Mycobacterium tuberculosis Transmission of TB M. tuberculosis is carried in airborne particles, called droplet nuclei, of 1– 5 microns in diameter. Infectious droplet nuclei are generated when persons who have pulmonary or laryngeal TB disease cough, sneeze, shout, or sing. Depending on the environment, these tiny particles can remain suspended in the air for several hours. M. tuberculosis is transmitted through the air, not by surface contact. Transmission occurs when a person inhales droplet nuclei containing M. -
An Uncommon Association of Tuberculous and Pyogenic Bacteria
Open Access Austin Journal of Clinical Neurology Research Article CNS Bacterial Coinfections: An Uncommon Association of Tuberculous and Pyogenic Bacteria Patricia V1, Luis SHJ2, Armando RPJ3, Ibis DLC1 and Graciela C2* Abstract 1 Department of Infectious Diseases, Instituto Nacional de Background: Pyogenic bacteria-tuberculosis coinfections in the CNS are Cancerología, Mexico uncommon, but some isolated cases have been reported. In contrast with other 2Department of Neuroinfectology, Instituto Nacional de coinfections, they also can be observed in non-immunosuppressed patients. Neurología y Neurocirugía, Mexico 3Department of Radiology, Instituto Nacional de Tuberculosis is still a major global health problem. CNS tuberculosis is Cancerología, México the most severe form of extrapulmonary tuberculosis, and when associated with pyogenic bacterial infections it shows atypical clinical and radiological *Corresponding author: Graciela Cárdenas, characteristics that make an accurate diagnosis difficult. Department of Neuroinfectology, Instituto Nacional de Neurología y Neurocirugía, Av. Insurgentes sur 3877, Methods: A case series of tuberculosis-pyogenic bacterial CNS coinfection Tlalpan, La fama, 14269, Mexico in patients attended at two referral centers in Mexico City during the last 5 years. Received: August 04, 2017; Accepted: September 18, Results: Evident immunosuppressive factors were observed in two of them. 2017; Published: October 31, 2017 Specific antituberculous treatment was delayed in all three cases due to their atypical clinical -
The Paleopathological Evidence on the Origins of Human Tuberculosis: a Review
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Journal of Preventive Medicine and Hygiene (JPMH) J PREV MED HYG 2020; 61 (SUPPL. 1): E3-E8 OPEN ACCESS The paleopathological evidence on the origins of human tuberculosis: a review I. BUZIC1,2, V. GIUFFRA1 1 Division of Paleopathology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Italy; 2 Doctoral School of History, “1 Decembrie 1918” University of Alba Iulia, Romania Keywords Tuberculosis • Paleopathology • History • Neolithic Summary Tuberculosis (TB) has been one of the most important infectious TB has a human origin. The researches show that the disease was diseases affecting mankind and still represents a plague on a present in the early human populations of Africa at least 70000 global scale. In this narrative review the origins of tuberculosis years ago and that it expanded following the migrations of Homo are outlined, according to the evidence of paleopathology. In par- sapiens out of Africa, adapting to the different human groups. The ticular the first cases of human TB in ancient skeletal remains demographic success of TB during the Neolithic period was due to are presented, together with the most recent discoveries result- the growth of density and size of the human host population, and ing from the paleomicrobiology of the tubercle bacillus, which not the zoonotic transfer from cattle, as previously hypothesized. provide innovative information on the history of TB. The paleo- pathological evidence of TB attests the presence of the disease These data demonstrate a long coevolution of the disease and starting from Neolithic times. -
5585665076Index-TB Guidelines.Pdf
Initiative of Central TB Division Ministry of Health and Family Welfare, Government of India ii INDEX-TB GUIDELINES - Guidelines on extra-pulmonary tuberculosis for India Convenors Department of Medicine, All India Institute of Medical Sciences, New Delhi WHO Collaborating Centre (WHO-CC) for Training and Research in Tuberculosis Centre of Excellence for Extra-Pulmonary Tuberculosis, Ministry of Health and Family Welfare, Government of India Partners Global Health Advocates, India Cochrane Infectious Diseases Group Cochrane South Asia World Health Organization Country Office for India © World Health Organization 2016 All rights reserved. The World Health Organization Country Office for India welcomes requests for permission to reproduce or translate its publications, in part or in full. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. -
Diagnosis of Tuberculosis in Adults and Children David M
Clinical Infectious Diseases IDSA GUIDELINE Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children David M. Lewinsohn,1,a Michael K. Leonard,2,a Philip A. LoBue,3,a David L. Cohn,4 Charles L. Daley,5 Ed Desmond,6 Joseph Keane,7 Deborah A. Lewinsohn,1 Ann M. Loeffler,8 Gerald H. Mazurek,3 Richard J. O’Brien,9 Madhukar Pai,10 Luca Richeldi,11 Max Salfinger,12 Thomas M. Shinnick,3 Timothy R. Sterling,13 David M. Warshauer,14 and Gail L. Woods15 1Oregon Health & Science University, Portland, Oregon, 2Emory University School of Medicine and 3Centers for Disease Control and Prevention, Atlanta, Georgia, 4Denver Public Health Department, Denver, Colorado, 5National Jewish Health and the University of Colorado Denver, and 6California Department of Public Health, Richmond; 7St James’s Hospital, Dublin, Ireland; 8Francis J. Curry International TB Center, San Francisco, California; 9Foundation for Innovative New Diagnostics, Geneva, Switzerland; 10McGill University and McGill International TB Centre, Montreal, Canada; 11University of Southampton, United Kingdom; 12National Jewish Health, Denver, Colorado, 13Vanderbilt University School of Medicine, Vanderbilt Institute for Global Health, Nashville, Tennessee, 14Wisconsin State Laboratory of Hygiene, Madison, and 15University of Arkansas for Medical Sciences, Little Rock Downloaded from Background. Individuals infected with Mycobacterium tuberculosis (Mtb) may develop symptoms and signs of disease (tuber- culosis disease) or may have no clinical evidence of disease (latent tuberculosis infection [LTBI]). Tuberculosis disease is a leading cause of infectious disease morbidity and mortality worldwide, yet many questions related to its diagnosis remain. -
Does BCG Vaccine Prevent Tuberculous Meningitis?
144 Archives ofDisease in Childhood 1996; 74: 144-147 Does BCG vaccine prevent tuberculous meningitis? N Thilothammal, P V Krishnamurthy, Desmond K Runyan, K Banu Abstract A prospective study with sufficient power to The reported efficacy of BCG vaccine in establish efficacy is not easy to conduct. Hence preventing pulmonary tuberculosis varies a case-control study was designed to find out from 0-80%; however, its efficacy in pre- the efficacy of BCG vaccine in preventing venting tuberculous meningitis ranges tuberculous meningitis. This study also from 520/%-84%. A case-control study was assessed the role of poor nutrition and low conducted to assess the efficacy of BCG in socioeconomic status in the development of preventing tuberculous meningitis in tuberculous meningitis. children. New cases oftuberculous menin- gitis, confirmed bacteriologically, were registered as cases. Controls were children Patients and methods suffering from febrile convulsions attend- SELECTION OF CASES ing the same hospital. A total of 107 cases This study was conducted at the Institute of and 321 controls, block matched for age, Child Health and Hospital for Children, were registered. Vaccination status was Madras, from August 1990-December 1992. determined from the history reported by Children aged 12 years or less were included in the mother and by BCG scar reading. the study. Data regarding socioeconomic status, Cases were selected from the inpatient crowding, and nutritional status were col- department of the hospital. Inclusion criteria lected. Using -
A Surgical Revisitation of Pott Distemper of the Spine Larry T
The Spine Journal 3 (2003) 130–145 Review Articles A surgical revisitation of Pott distemper of the spine Larry T. Khoo, MD, Kevin Mikawa, MD, Richard G. Fessler, MD, PhD* Institute for Spine Care, Chicago Institute of Neurosurgery and Neuroresearch, Rush Presbyterian Medical Center, Chicago, IL 60614, USA Received 21 January 2002; accepted 2 July 2002 Abstract Background context: Pott disease and tuberculosis have been with humans for countless millennia. Before the mid-twentieth century, the treatment of tuberculous spondylitis was primarily supportive and typically resulted in dismal neurological, functional and cosmetic outcomes. The contemporary development of effective antituberculous medications, imaging modalities, anesthesia, operative techniques and spinal instrumentation resulted in quantum improvements in the diagnosis, manage- ment and outcome of spinal tuberculosis. With the successful treatment of tuberculosis worldwide, interest in Pott disease has faded from the surgical forefront over the last 20 years. With the recent unchecked global pandemic of human immunodeficiency virus, the number of tuberculosis and sec- ondary spondylitis cases is again increasing at an alarming rate. A surgical revisitation of Pott dis- ease is thus essential to prepare spinal surgeons for this impending resurgence of tuberculosis. Purpose: To revisit the numerous treatment modalities for Pott disease and their outcomes. From this information, a critical reappraisal of surgical nuances with regard to decision making, timing, operative approach, graft types and the use of instrumentation were conducted. Study design: A concise review of the diagnosis, management and surgical treatment of Pott disease. Methods: A broad review of the literature was conducted with a particular focus on the different surgical treatment modalities for Pott disease and their outcomes regarding neurological deficit, ky- phosis and spinal stability.